Overview
INNOVATE Q3 revenue rises 43.3% yr/yr, driven by Infrastructure segment growth
Co, which has portfolio of assets in infrastructure, life sciences and spectrum, posts Q3 net loss of $9.4 mln vs loss of $15.3 mln yr ago
Adjusted EBITDA for Q3 increases to $19.8 mln from $16.8 mln yr/yr
Outlook
Company expects MediBeacon's TGFR system to be available in China by year-end
Company sees emerging opportunities in datacasting with Spectrum
Result Drivers
INFRASTRUCTURE GROWTH - DBM Global's strong revenue growth driven by commercial structural steel fabrication and erection projects
REGULATORY APPROVAL - MediBeacon received approval to sell Transdermal GFR System in China, expanding market reach
ADVERTISING RECOVERY - Spectrum's Q4 advertising sales show early signs of recovery amid new network launches
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Revenue | $347.10 mln | ||
Q3 EPS | -$0.71 | ||
Q3 Net Income | -$9.40 mln | ||
Q3 Adjusted EBITDA | $19.80 mln |
Press Release: ID:nGNX2YZvYw
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)